Antiviral Compounds for Blocking Arboviral Transmission in Mosquitoes

@article{Dong2021AntiviralCF,
  title={Antiviral Compounds for Blocking Arboviral Transmission in Mosquitoes},
  author={Shengzhang Dong and George Dimopoulos},
  journal={Viruses},
  year={2021},
  volume={13}
}
Mosquito-borne arthropod-borne viruses (arboviruses) such as the dengue virus (DENV), Zika virus (ZIKV), and chikungunya virus (CHIKV) are important human pathogens that are responsible for significant global morbidity and mortality. The recent emergence and re-emergence of mosquito-borne viral diseases (MBVDs) highlight the urgent need for safe and effective vaccines, therapeutics, and vector-control approaches to prevent MBVD outbreaks. In nature, arboviruses circulate between vertebrate… 

Tables from this paper

Favipiravir Does Not Inhibit Chikungunya Virus Replication in Mosquito Cells and Aedes aegypti Mosquitoes
TLDR
In vitro and in vivo data indicate that T-705 lacks antiviral activity in mosquitoes due to inadequate metabolic activation in this animal species.
Coupled small molecules target RNA interference and JAK/STAT signaling to reduce Zika virus infection in Aedes aegypti
TLDR
This work demonstrates that targeting insulin signaling through the repurposing of small molecule drugs results in the activation of both of these antiviral pathways, indicating the potential for field delivery of these small molecules to substantially reduce virus transmission.
Coupled small molecules target RNA interference and JAK/STAT signaling to reduce Zika virus infection in Aedes aegypti
TLDR
The potential for field delivery of these small molecules to substantially reduce virus transmission from mosquito to human is indicated, and this work demonstrates that targeting insulin signaling through the repurposing of small molecule drugs results in the activation of both RNAi and JAK/STAT antiviral pathways.
Current Status of Chikungunya in India
TLDR
The current status of CHIKF in India is presented and several mutations have been identified in circulating strains of the virus resulting in better adaptations or increased fitness in the vector(s), effective transmission, and disease severity.
Current Status of Chikungunya in India
  • Anitha Anup Naren Piya Paul Robin Shahin Ujwal Dileep Kum Jagadesh Jayaram Babu Mudgal Sudandiradas Sheik Sh
  • Medicine
    Frontiers in Microbiology
  • 2021
TLDR
The current status of CHIKF in India is presented and several mutations have been identified in circulating strains of the virus resulting in better adaptations or increased fitness in the vector(s), effective transmission, and disease severity.

References

SHOWING 1-10 OF 120 REFERENCES
Rapid selection against arbovirus-induced apoptosis during infection of a mosquito vector
TLDR
The results indicate that apoptosis is a strong antiviral response in mosquitoes and may explain why it is usually not observed in coevolved arbovirus–vector relationships, and suggests that arBoviruses have evolved mechanisms to avoid stimulating apoptosis in mosquitoes that serve as vectors.
Mosquito Immunity against Arboviruses
TLDR
Recent findings concerning the role of the mosquito immune system in antiviral defense, interactions between arboviruses and fundamental cellular processes such as apoptosis and autophagy, and arBoviral suppression of mosquito defense mechanisms are discussed.
Identification of anti-flaviviral drugs with mosquitocidal and anti-Zika virus activity in Aedes aegypti
TLDR
A comprehensive screen of 55 FDA-approved anti-flaviviral drugs for potential anti-ZIKV and mosquitocidal activity is presented and six drugs significantly suppressed ZIKV infection in mosquito midguts.
Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases.
TLDR
This work discusses Dengue, yellow fever, chikungunya, and Zika viruses, recent arrivals in the Western Hemisphere, and a few other viruses with the potential to emerge through all of these mechanisms.
Suppressing Dengue-2 Infection by Chemical Inhibition of Aedes aegypti Host Factors
TLDR
Proof-of-principle is provided that chemical inhibition or RNAi-mediated depletion of the DENV HFs vATPase and IMPDH can be used to suppress DENV infection of adult A. aegypti mosquitoes, which may translate to a reduction in DENV transmission.
The Aedes aegypti Toll Pathway Controls Dengue Virus Infection
TLDR
It is shown that the mosquito's natural microbiota play a role in modulating the dengue virus infection, possibly through basal-level stimulation of the Toll immune pathway, as indicated by an infection-responsive regulation and functional assessment of several Toll pathway–associated genes.
Broad Dengue Neutralization in Mosquitoes Expressing an Engineered Antibody
TLDR
These mosquitoes express a gene encoding an engineered single-chain variable fragment derived from a broadly neutralizing DENV human monoclonal antibody and have significantly reduced viral infection, dissemination, and transmission rates for all four major antigenically distinct DENV serotypes.
Dengue Virus Type 2 Infections of Aedes aegypti Are Modulated by the Mosquito's RNA Interference Pathway
TLDR
It is shown that although dengue virus type 2 (DENV2) infection of Ae.
Exposing Anopheles mosquitoes to antimalarials blocks Plasmodium parasite transmission
TLDR
It is shown that the development of P. falciparum can be rapidly and completely blocked when female Anopheles gambiae mosquitoes take up low concentrations of specific antimalarials from treated surfaces—conditions that simulate contact with a bed net.
Engineered resistance to Zika virus in transgenic Aedes aegypti expressing a polycistronic cluster of synthetic small RNAs
TLDR
The generation of Aedes aegypti mosquitoes that are engineered to be resistant to Zika virus (ZIKV) transmission is described, and a polycistronic cluster of engineered synthetic small RNAs targeting ZIKV is demonstrated, ensuring the formation of mature synthetic smallRNAs in the midgut where ZikV resides in the early stages of infection.
...
1
2
3
4
5
...